In this study, researchers evaluated the effects of L-carnitine supplementation on lipid parameters, apoproteins and inflammatory and nutritional markers in maintenance hemodialysis (MHD) patients. Patients with end-stage renal disease on MHD for a period of 2 to 5 years were divided into 2 groups: the carnitine group received 1 g supplementation intravenously three times a week after each hemodialysis session, and the control group received no supplementation with L-carnitine. Highly sensitive C-reactive protein (hsCRP), total protein, albumin, lipid profile and apoprotein AI and B were determined at baseline and at the end of the study.
A significant decrease in the hsCRP levels was observed in the carnitine-supplemented group, which suggests that L-carnitine supplementation may reduce inflammation in MHD patients.
Source: The effect of L-Carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients (full-text)
This is also my last post before I take time off for the holidays. So I'll leave you with this video a friend sent...
Related posts on L-carnitine:
- Advantages of L-carnitine in Treating Hepatitis C
- L-Carnitine May Protect Mitochondrial Function in Liver
- L-Carnitine May Reduce Oxidative Damage
- L-Carnitine Helps Treat Autism Spectrum Disorders
- L-Carnitine May Help Kids with Asthma
- L-Carnitine Benefits Huntington's Disease
Click HERE to subscribe to Know Guff by email